dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii has been researched along with Plasma Cell Tumor in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berger, M; Engel, J; Jennerwein, M; Schönenberger, H; von Angerer, E; Wappes, B; Wrobel, KH | 1 |
1 other study(ies) available for dichloro(1,2-bis(4-hydroxyphenyl)ethylenediamine)platinum ii and Plasma Cell Tumor
Article | Year |
---|---|
Dichloro[1,2-bis(4-hydroxyphenyl)ethylenediamine]platinum(II) complexes: an approach to develop compounds with a specific effect on the hormone-dependent mammary carcinoma.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line; Drug Evaluation, Preclinical; Estradiol; Female; Humans; Indicators and Reagents; Leukemia, Experimental; Mice; Mice, Inbred BALB C; Molecular Conformation; Organoplatinum Compounds; Plasmacytoma; Rats; Rats, Inbred Strains; Receptors, Estradiol; Structure-Activity Relationship | 1984 |